Current with legislation from the 2023 Regular and Special Sessions signed by the Governor as of November 21, 2023.
Section 441.0051 - Annual Report Not later than the 15th day of each calendar year, a pharmaceutical drug manufacturer shall submit a report to the department stating the current wholesale acquisition cost information for the United States Food and Drug Administration-approved prescription drugs sold in or into this state by that manufacturer.
Tex. Health and Safety Code § 441.0051
Subchapter heading added by Acts 2021, Texas Acts of the 87th Leg. - Regular Session, ch. 50,Sec. 2, eff. 9/1/2021.Renumbered from Tex. Health and Safety Code § 441.0002 and amended by Acts 2021, Texas Acts of the 87th Leg. - Regular Session, ch. 50,Sec. 3, eff. 9/1/2021.Added by Acts 2019, Texas Acts of the 86th Leg.- Regular Session, ch. 1291,Sec. 1, eff. 9/1/2019.